{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T01:27:25Z","timestamp":1789522045169,"version":"build-2803163510"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.radonc.2026.111446","type":"journal-article","created":{"date-parts":[[2026,2,15]],"date-time":"2026-02-15T23:34:36Z","timestamp":1771198476000},"page":"111446","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Prospective Phase 2 Trial: Long-term results of a salvage brachytherapy combined with interstitial hyperthermia as Re-Irradiation for locally recurrent prostate Carcinoma"],"prefix":"10.1016","volume":"218","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3871-7563","authenticated-orcid":false,"given":"Vratislav","family":"Strnad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateusz","family":"D\u0105bkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"D\u0105browski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Brandys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Kulik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewelina","family":"Gruszczy\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver Josef","family":"Ott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annedore Renate","family":"Strnad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfred","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Lotter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Kreppner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricarda","family":"Merten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Fietkau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8709-7252","authenticated-orcid":false,"given":"Stefanie","family":"Corradini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9940-0204","authenticated-orcid":false,"given":"Andrzej Marek","family":"Kukie\u0142ka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.radonc.2026.111446_b0005","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.6004\/jnccn.2023.0050","article-title":"Prostate cancer, version 4.2023, NCCN clinical practice guidelines in oncology","volume":"21","author":"Schaeffer","year":"2023","journal-title":"J Natl Compr Canc Netw"},{"issue":"2","key":"10.1016\/j.radonc.2026.111446_b0010","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","article-title":"EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer-2024 update. part i: screening, diagnosis, and local treatment with curative intent","volume":"86","author":"Cornford","year":"2024","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.radonc.2026.111446_b0015","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.eururo.2020.11.010","article-title":"A systematic review and meta-analysis of local salvage therapies after radiotherapy for prostate cancer (MASTER)","volume":"80","author":"Valle","year":"2021","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.radonc.2026.111446_b0020","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/j.juro.2015.06.100","article-title":"Anatomical patterns of recurrence following biochemical relapse in the dose escalation era of external beam radiotherapy for prostate cancer","volume":"194","author":"Zumsteg","year":"2015","journal-title":"J Urol"},{"issue":"15","key":"10.1016\/j.radonc.2026.111446_b0025","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1200\/JCO.2015.64.8055","article-title":"Short androgen suppression and radiation dose escalation for intermediate- and high-risk localized prostate cancer: results of EORTC Trial 22991","volume":"34","author":"Bolla","year":"2016","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.radonc.2026.111446_b0030","doi-asserted-by":"crossref","first-page":"4789","DOI":"10.1007\/s00330-023-10442-4","article-title":"Recurrent prostate cancer: combined role for MRI and PSMA-PET in (68)Ga-PSMA-11 PET\/MRI","volume":"34","author":"Jannusch","year":"2024","journal-title":"Eur Radiol"},{"issue":"1","key":"10.1016\/j.radonc.2026.111446_b0035","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ijrobp.2019.05.003","article-title":"Multiparametric MRI tumor probability model for the detection of locally recurrent prostate cancer after radiation therapy: pathologic validation and comparison with manual tumor delineations","volume":"105","author":"Dinis Fernandes","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"14","key":"10.1016\/j.radonc.2026.111446_b0040","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1002\/pros.23406","article-title":"Avoidance of androgen deprivation therapy in radiorecurrent prostate cancer as a clinically meaningful endpoint for salvage cryoablation","volume":"77","author":"Ginsburg","year":"2017","journal-title":"Prostate"},{"issue":"6","key":"10.1016\/j.radonc.2026.111446_b0045","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1089\/end.2015.0719","article-title":"Five-Year biochemical progression-free survival following salvage whole-gland prostate cryoablation: defining success with nadir prostate-specific antigen","volume":"30","author":"Kovac","year":"2016","journal-title":"J Endourol"},{"issue":"2","key":"10.1016\/j.radonc.2026.111446_b0050","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ijrobp.2019.10.014","article-title":"Retreatment for local recurrence of prostatic carcinoma after prior therapeutic irradiation: efficacy and Toxicity of HDR-Like SBRT","volume":"106","author":"Fuller","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.radonc.2026.111446_b0055","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1159\/000371893","article-title":"Salvage radical prostatectomy after external beam radiation therapy: a systematic review of current approaches","volume":"94","author":"Matei","year":"2015","journal-title":"Urol Int"},{"issue":"8","key":"10.1016\/j.radonc.2026.111446_b0060","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s00066-024-02205-x","article-title":"Evaluation of the safety and efficacy of high-dose rate brachytherapy for radiorecurrent prostate cancer: a systematic review and meta-analysis","volume":"200","author":"Shen","year":"2024","journal-title":"Strahlenther Onkol"},{"issue":"5","key":"10.1016\/j.radonc.2026.111446_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2020.11.002","article-title":"Oncological outcomes of salvage radical prostatectomy for recurrent prostate cancer in the contemporary era: a multicenter retrospective study","volume":"39","author":"Marra","year":"2021","journal-title":"Urol Oncol"},{"issue":"6","key":"10.1016\/j.radonc.2026.111446_b0070","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1590\/s1677-5538.ibju.2023.0467","article-title":"Outcomes of Salvage robotic-assisted radical prostatectomy in the last decade: systematic review and perspectives of referral centers","volume":"49","author":"Moschovas","year":"2023","journal-title":"Int Braz J Urol"},{"issue":"22","key":"10.1016\/j.radonc.2026.111446_b0075","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15225485","article-title":"Salvage radical prostatectomy for recurrent prostate cancer: a systematic review (french ccAFU)","volume":"15","author":"Saouli","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"6 Pt 1","key":"10.1016\/j.radonc.2026.111446_b0080","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1097\/01.ju.0000140960.63108.39","article-title":"Morbidity and functional outcomes of salvage radical prostatectomy for locally recurrent prostate cancer after radiation therapy","volume":"172","author":"Stephenson","year":"2004","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.radonc.2026.111446_b0085","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.ijrobp.2004.09.049","article-title":"Long-term oncologic results of salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy","volume":"62","author":"Bianco","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.radonc.2026.111446_b0090","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.ijrobp.2009.06.061","article-title":"Long-term outcome and toxicity of salvage brachytherapy for local failure after initial radiotherapy for prostate cancer","volume":"77","author":"Burri","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.radonc.2026.111446_b0095","first-page":"105","article-title":"HDR brachytherapy as a solution in recurrences of locally advanced prostate cancer","volume":"1","author":"Lyczek","year":"2009","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.radonc.2026.111446_b0100","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.radonc.2020.06.031","article-title":"Long-term results of a protocol-based ultrasound-guided salvage brachytherapy as re-irradiation for local recurrent prostate cancer","volume":"150","author":"Schonle","year":"2020","journal-title":"Radiother Oncol"},{"issue":"6","key":"10.1016\/j.radonc.2026.111446_b0105","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.brachy.2017.08.008","article-title":"van der Voort van Zyp JRN. Salvage brachytherapy for radiorecurrent prostate cancer: Searching for safety and success","volume":"16","author":"Peters","year":"2017","journal-title":"Brachytherapy"},{"issue":"2","key":"10.1016\/j.radonc.2026.111446_b0110","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.brachy.2013.11.005","article-title":"A phase II study of salvage high-dose-rate brachytherapy for the treatment of locally recurrent prostate cancer after definitive external beam radiotherapy","volume":"13","author":"Yamada","year":"2014","journal-title":"Brachytherapy"},{"issue":"4","key":"10.1016\/j.radonc.2026.111446_b0115","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.canrad.2018.01.005","article-title":"Salvage brachytherapy as a modern reirradiation technique for local cancer failure: the Phoenix is reborn from its ashes","volume":"22","author":"Quivrin","year":"2018","journal-title":"Cancer Radiother"},{"issue":"2","key":"10.1016\/j.radonc.2026.111446_b0120","doi-asserted-by":"crossref","first-page":"111","DOI":"10.5114\/jcb.2024.139278","article-title":"Acute toxicity outcomes from salvage high-dose-rate brachytherapy for locally recurrent prostate cancer after prior radiotherapy","volume":"16","author":"Fang","year":"2024","journal-title":"J Contemp Brachytherapy"},{"issue":"4","key":"10.1016\/j.radonc.2026.111446_b0125","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1007\/s12094-023-03315-1","article-title":"Reirradiation salvage radiotherapy for recurrent prostate cancer after primary low-dose brachytherapy","volume":"26","author":"Munoz Munoz","year":"2024","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.radonc.2026.111446_b0130","article-title":"Salvage low-dose-rate brachytherapy for locally recurrent prostate cancer after definitive irradiation","volume":"48","author":"Meraouna","year":"2024","journal-title":"Clin Transl Radiat Oncol"},{"issue":"1","key":"10.1016\/j.radonc.2026.111446_b0135","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0360-3016(95)02017-9","article-title":"Preferential radiosensitization of human prostatic carcinoma cells by mild hyperthermia","volume":"34","author":"Ryu","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.radonc.2026.111446_b0140","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1080\/02656736.2022.2053212","article-title":"Combined hyperthermia and radiotherapy for prostate cancer: a systematic review","volume":"39","author":"Le Guevelou","year":"2022","journal-title":"Int J Hyperth"},{"issue":"1095","key":"10.1016\/j.radonc.2026.111446_b0145","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20180759","article-title":"Mild hyperthermia as a localized radiosensitizer for deep-seated tumors: investigation in an orthotopic prostate cancer model in mice","volume":"92","author":"Cohen","year":"2019","journal-title":"Br J Radiol"},{"issue":"2","key":"10.1016\/j.radonc.2026.111446_b0150","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/09553002.2019.1532608","article-title":"Capacitive hyperthermia as an alternative to brachytherapy in DNA damages of human prostate cancer cell line (DU-145)","volume":"95","author":"Mahdavi","year":"2019","journal-title":"Int J Radiat Biol"},{"issue":"1","key":"10.1016\/j.radonc.2026.111446_b0155","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1464-410X.2004.04551.x","article-title":"Radiotherapy and hyperthermia in the treatment of patients with locally advanced prostate cancer: preliminary results","volume":"93","author":"Van Vulpen","year":"2004","journal-title":"BJU Int"},{"issue":"1","key":"10.1016\/j.radonc.2026.111446_b0160","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00066-005-1296-8","article-title":"Regional hyperthermia in conjunction with definitive radiotherapy against recurrent or locally advanced prostate cancer T3 pN0 M0","volume":"181","author":"Tilly","year":"2005","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.radonc.2026.111446_b0165","first-page":"1","article-title":"Definitive radiotherapy plus regional hyperthermia for high-risk and very high-risk prostate carcinoma: thermal parameters correlated with biochemical relapse-free survival","author":"Yahara","year":"2015","journal-title":"Int J Hyperth"},{"issue":"3","key":"10.1016\/j.radonc.2026.111446_b0170","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/0360-3016(91)90068-F","article-title":"Secondary external-beam radiotherapy and hyperthermia for local recurrence after 125-iodine implantation in adenocarcinoma of the prostate","volume":"20","author":"Kaplan","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.radonc.2026.111446_b0175","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00066-013-0486-z","article-title":"Salvage prostate HDR brachytherapy combined with interstitial hyperthermia for local recurrence after radiation therapy failure","volume":"190","author":"Kukielka","year":"2014","journal-title":"Strahlenther Onkol"},{"issue":"5","key":"10.1016\/j.radonc.2026.111446_b0180","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13051133","article-title":"Salvage-Radiation Therapy and Regional Hyperthermia for Biochemically Recurrent Prostate Cancer after Radical Prostatectomy (results of the Planned Interim Analysis)","volume":"13","author":"Beck","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.radonc.2026.111446_b0185","unstructured":"Common Terminology Criteria for Adverse Events (CTCAE)Version 4.0; available at: http:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/ctc.htm#ctc_40."},{"issue":"4","key":"10.1016\/j.radonc.2026.111446_b0190","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.ijrobp.2006.04.029","article-title":"Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference","volume":"65","author":"Roach","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2S","key":"10.1016\/j.radonc.2026.111446_b0195","doi-asserted-by":"crossref","first-page":"S189","DOI":"10.1016\/j.juro.2016.10.071","article-title":"The American Urological Association Symptom Index for Benign Prostatic Hyperplasia","volume":"197","author":"Barry","year":"2017","journal-title":"J Urol"},{"issue":"6","key":"10.1016\/j.radonc.2026.111446_b0200","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/sj.ijir.3900472","article-title":"Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction","volume":"11","author":"Rosen","year":"1999","journal-title":"Int J Impot Res"},{"issue":"2","key":"10.1016\/j.radonc.2026.111446_b0205","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.radonc.2012.07.003","article-title":"Long term results of a prospective dose escalation phase-II trial: interstitial pulsed-dose-rate brachytherapy as boost for intermediate- and high-risk prostate cancer","volume":"104","author":"Lettmaier","year":"2012","journal-title":"Radiother Oncol"},{"issue":"8","key":"10.1016\/j.radonc.2026.111446_b0210","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1007\/s00066-013-0373-7","article-title":"Protocol-based image-guided salvage brachytherapy. Early results in patients with local failure of prostate cancer after radiation therapy","volume":"189","author":"Lahmer","year":"2013","journal-title":"Strahlenther Onkol"},{"issue":"4","key":"10.1016\/j.radonc.2026.111446_b0215","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0360-3016(01)01607-8","article-title":"Is alpha\/beta for prostate tumors really low?","volume":"50","author":"Fowler","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.radonc.2026.111446_b0220","first-page":"133","article-title":"Brachytherapy for prostate cancer: summary of American Brachytherapy Society recommendations","volume":"18","author":"Nag","year":"2000","journal-title":"Semin Urol Oncol"},{"issue":"2","key":"10.1016\/j.radonc.2026.111446_b0225","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.radonc.2004.09.004","article-title":"GEC\/ESTRO-EAU recommendations on temporary brachytherapy using stepping sources for localised prostate cancer","volume":"74","author":"Kovacs","year":"2005","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.radonc.2026.111446_b0230","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1080\/02656736.2018.1564155","article-title":"Quality assurance guidelines for interstitial hyperthermia","volume":"36","author":"Dobsicek Trefna","year":"2019","journal-title":"Int J Hyperth"},{"issue":"5","key":"10.1016\/j.radonc.2026.111446_b0235","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/0360-3016(91)90213-N","article-title":"RTOG quality assurance guidelines for interstitial hyperthermia","volume":"20","author":"Emami","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"10.1016\/j.radonc.2026.111446_b0240","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.brachy.2017.07.013","article-title":"Salvage brachytherapy for recurrent prostate cancer after definitive radiation therapy: a comparison of low-dose-rate and high-dose-rate brachytherapy and the importance of prostate-specific antigen doubling time","volume":"16","author":"Kollmeier","year":"2017","journal-title":"Brachytherapy"},{"issue":"4","key":"10.1016\/j.radonc.2026.111446_b0245","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.brachy.2022.01.005","article-title":"Efficacy and toxicity following salvage high-dose-rate brachytherapy for locally recurrent prostate cancer after radiotherapy","volume":"21","author":"Kissel","year":"2022","journal-title":"Brachytherapy"},{"issue":"9","key":"10.1016\/j.radonc.2026.111446_b0250","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s00066-017-1157-2","article-title":"High-dose-rate brachytherapy as salvage modality for locally recurrent prostate cancer after definitive radiotherapy : a systematic review","volume":"193","author":"Chatzikonstantinou","year":"2017","journal-title":"Strahlenther Onkol"},{"issue":"4","key":"10.1016\/j.radonc.2026.111446_b0255","doi-asserted-by":"crossref","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.radonc.2026.111446_b0260","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3109\/02656730903479855","article-title":"The effect of mild temperature hyperthermia on tumour hypoxia and blood perfusion: relevance for radiotherapy, vascular targeting and imaging","volume":"26","author":"Sun","year":"2010","journal-title":"Int J Hyperth"},{"issue":"5","key":"10.1016\/j.radonc.2026.111446_b0265","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1080\/02656730701553260","article-title":"Conformal radiotherapy plus local hyperthermia in patients affected by locally advanced high risk prostate cancer: preliminary results of a prospective phase II study","volume":"23","author":"Maluta","year":"2007","journal-title":"Int J Hyperth"},{"issue":"2","key":"10.1016\/j.radonc.2026.111446_b0270","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0302-2838(02)00277-4","article-title":"Interstitial hyperthermia using self-regulating thermoseeds combined with conformal radiation therapy","volume":"42","author":"Deger","year":"2002","journal-title":"Eur Urol"},{"key":"10.1016\/j.radonc.2026.111446_b0275","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/cncr.25619","article-title":"Hyperthermia combined with radiation for the treatment of locally advanced prostate cancer: long-term results from Dana-Farber Cancer Institute study 94-153","volume":"117","author":"Hurwitz","year":"2011","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.radonc.2026.111446_b0280","doi-asserted-by":"crossref","first-page":"600","DOI":"10.3109\/02656736.2015.1062214","article-title":"Definitive radiotherapy plus regional hyperthermia for high-risk and very high-risk prostate carcinoma: thermal parameters correlated with biochemical relapse-free survival","volume":"31","author":"Yahara","year":"2015","journal-title":"Int J Hyperth"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016781402600085X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016781402600085X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T20:13:02Z","timestamp":1781122382000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016781402600085X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":56,"alternative-id":["S016781402600085X"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2026.111446","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prospective Phase 2 Trial: Long-term results of a salvage brachytherapy combined with interstitial hyperthermia as Re-Irradiation for locally recurrent prostate Carcinoma","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2026.111446","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"111446"}}